GEXVal CEO to Speak at China Healthcare Summit 2025

GEXVal Inc.
October 20, 2025

GEXVal CEO Invited and to Speak at BioCentury-BayHelix China Healthcare Summit 2025

GEXVal Inc. (President and CEO: Juran Kato, PhD; Location: Fujisawa, Kanagawa, Japan, hereinafter “GEXVal”) is pleased to announce that President and CEO Dr. Juran Kato has been invited to speak at the BioCentury-BayHelix China Healthcare Summit 2025 roundtable discussion, co-hosted by BioCentury and BayHelix.

[Event Overview]
The China Healthcare Summit is one of the Asia-Pacific region's largest international biotech events, bringing together global pharmaceutical companies, investors, biotech ventures, and ecosystem partners. This premier platform facilitates partnership building and licensing deals across the biotechnology landscape. The roundtable will focus on the "Arc of Innovation" emerging across Asia—from Japan and Korea to Singapore and India—with biotech CEOs discussing global expansion strategies and partnerships with Western markets.

**Presentation Details**

[CEO Statement]
“I’m deeply honored to join this remarkable summit as Japan’s representative. I’m looking forward to connecting with inspiring biotech leaders across Asia to explore how we can turn innovation into real benefits for patients and their families worldwide. Together, I hope we can spark collaborations that create lasting, positive impact — a mission that truly brings us all together.”

[About GEXVal]
GEXVal strives to create and develop innovative pharmaceuticals for unmet medical needs, ensuring Treatment Reaches the Unreached with focus on rare diseases and underserved medical conditions. By leveraging our proprietary AI-powered pharmacoinformatics technology, we illuminate paths to breakthrough therapies, identifying hidden potential in drug candidates to deliver life-changing medicines that bring new hope to patients and their families.

For further information:
Head of Corporate Office
Atsushi Sugizaki
info@gexval.com